Related Experiment Video
Updated: Jul 12, 2025

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Cerebral Small Vessel Disease: a Review of the Pathophysiological Mechanisms
1Division of Cerebrovascular Diseases and Neurocritical Care, Department of Neurology, The Ohio State University, 333 West 10th Ave, Graves Hall 3172C, Columbus, OH, 43210, USA. yousefhannawi@yahoo.com.
Insights
Cerebral small vessel disease (cSVD) involves aging brain processes affecting small vessels. Understanding these mechanisms is key to developing new treatments for cSVD, which causes cognitive decline and stroke.
Area of Science:
- Neurology
- Vascular Biology
- Aging Research
Background:
- Cerebral small vessel disease (cSVD) is a major cause of vascular cognitive impairment and stroke.
- Current understanding of cSVD pathogenesis is incomplete, limiting therapeutic development.
Purpose of the Study:
- To review and synthesize current knowledge on cSVD pathophysiological mechanisms.
- To identify knowledge gaps and propose future research directions for cSVD therapeutics.
Main Methods:
- Review of recent advances in neuroimaging and animal models of cSVD.
- Analysis of age-dependent processes implicated in cSVD pathogenesis.
- Discussion of the interaction between various pathological factors.
Main Results:
- cSVD involves arterial stiffness, oxidative stress, inflammation, gut dysbiosis, and high salt intake.
- These factors lead to endothelial dysfunction, blood-brain barrier breakdown, and neuroinflammation.
- Impaired glymphatic system function contributes to cognitive decline in cSVD.
Conclusions:
- Multiple interacting age-dependent mechanisms drive cSVD.
- Further research is needed to elucidate complex interactions and develop targeted therapies.
- A systematic approach to translational and early-phase clinical research is proposed.
Abstract:
Cerebral small vessel disease (cSVD) refers to the age-dependent pathological processes involving the brain small vessels and leading to vascular cognitive impairment, intracerebral hemorrhage, and acute lacunar ischemic stroke. Despite the significant public health burden of cSVD, disease-specific therapeutics remain unavailable due to the incomplete understanding of the underlying pathophysiological mechanisms. Recent advances in neuroimaging acquisition and processing capabilities as well as findings from cSVD animal models have revealed critical roles of several age-dependent processes in cSVD pathogenesis including arterial stiffness, vascular oxidative stress, low-grade systemic inflammation, gut dysbiosis, and increased salt intake. These factors interact to cause a state of endothelial cell dysfunction impairing cerebral blood flow regulation and breaking the blood brain barrier. Neuroinflammation follows resulting in neuronal injury and cSVD clinical manifestations. Impairment of the cerebral waste clearance through the glymphatic system is another potential process that has been recently highlighted contributing to the cognitive decline. This review details these mechanisms and attempts to explain their complex interactions. In addition, the relevant knowledge gaps in cSVD mechanistic understanding are identified and a systematic approach to future translational and early phase clinical research is proposed in order to reveal new cSVD mechanisms and develop disease-specific therapeutics.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
The Blood-brain Barrier

